Major Hematological Response Is the Main Factor for Achieving a Major Molecular Response in JAK2V617F-Positive Essential Thrombocythemia and Polycythemia Vera Patients Treated with Hydroxyurea

被引：4
|
作者：
Besses, C. [1 ]
Alvarez-Larran, A. [1 ]
Martinez-Aviles, L. [1 ]
Longaron, R. [1 ]
Serrano, S. [1 ]
Bellosillo, B. [1 ]
机构：
[1] Hosp Mar, Barcelona, Spain
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
10.1182/blood.V112.11.660.660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [21] Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera
    Karkucak, Mutlu
    Yakut, Tahsin
    Ozkocaman, Vildan
    Ozkalemkas, Fahir
    Ali, Ridvan
    Bayram, Murat
    Gorukmez, Orhan
    Ocakoglu, Gokhan
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (09) : 8663 - 8667
  • [22] The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
    Lippert, Eric
    Boissinot, Marjorie
    Kralovics, Robert
    Girodon, Francois
    Dobo, Irene
    Praloran, Vincent
    Boiret-Dupre, Nathalie
    Skoda, Radek C.
    Hermouet, Sylvie
    BLOOD, 2006, 108 (06) : 1865 - 1867
  • [23] POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA: JAK2V617F MUTATION IS MORE COMMON IN OLDER PATIENTS
    Randi, M. L.
    Ruzzon, E.
    Scapin, M.
    Tezza, E.
    Bertozzi, I.
    Fabris, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 60 - 60
  • [24] Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera
    Mutlu Karkucak
    Tahsin Yakut
    Vildan Ozkocaman
    Fahir Ozkalemkas
    Ridvan Ali
    Murat Bayram
    Orhan Gorukmez
    Gokhan Ocakoglu
    Molecular Biology Reports, 2012, 39 : 8663 - 8667
  • [25] JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera
    Zhang, Sujiang
    Qiu, Hongxia
    Fischer, Bruce S.
    Li, Weida
    Duan, Limin
    Sun, Xuemei
    Xu, Wei
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 696 - 699
  • [26] Influence of JAK2V617F Allele Burden on Hematological Response in the Treatment of Polycythemia Vera
    Shikhbabaeva, Dzhariyat
    Shuvaev, Vasily
    Golovchenko, Regina
    Udaleva, Vera
    Fominykh, Mikhail
    Zotova, Irina I.
    Polushkina, Lyubov
    Martynkevich, Irina
    Abdulkadyrov, Kudrat
    BLOOD, 2016, 128 (22)
  • [27] Evaluation Of The JAK2-V617F Gene Mutation In Egyptian Patients With Essential Thrombocythemia and Polycythemia Vera
    El Zaafarany, Maha Ibrahim
    Abdel-Ghaffar, A. Hasan
    Elkhodary, Tawfik R.
    Salem, Dalia A.
    Soliman, Eman A.
    Shamaa, Sameh S.
    BLOOD, 2013, 122 (21)
  • [28] Dysregulated Autophagy in Platelets from JAK2V617F-Positive Polycythemia Vera and Essential Thrombocythemia Underlies Bioenergetic Failure As a Possible Mechanism for Thrombohemorrhagic Complications
    Sanchez, Guadalupe Rojas
    Esparza, Orlando
    McMahon, Brandon
    Hernandez, Giovanny
    Le, Dennis
    Nemkov, Travis
    D'Alessandro, Angelo
    Thorburn, Andrew
    Lopez, Jose A.
    Davizon-Castillo, Pavel
    BLOOD, 2022, 140 : 9590 - 9591
  • [29] Evidence for an environmental influence leading to the development of JAK2V617F-positive polycythemia vera:: A molecular epidemiological study
    Hoffman, Ronald
    Xu, Mingjiang
    Roda, Paul I.
    Jumaan, Aisha
    Lewis, Brian
    Gotway, Carol A.
    Seaman, Vincent
    BLOOD, 2007, 110 (11) : 85A - 85A
  • [30] Coexistence of Hermansky-Pudlak syndrome and JAK2V617F-positive essential thrombocythemia
    Eskazan, Tugce
    Erturkuner, Salime Pelin
    Isildar, Basak
    Eskazan, Ahmet Emre
    Ar, Muhlis Cem
    Atay, Kadri
    Baslar, Zafer
    Tasyurekli, Mustafa
    ULTRASTRUCTURAL PATHOLOGY, 2019, 43 (01) : 94 - 98
12345